Prediction of the Development of Osteoarthritis of the Hip Joint Based on Distribution of the Gene Encoding 5-Factor Gdf5 Growth Differentiations

Medical research confirms that inherited genetic tendencies strongly increase coxarthrosis development as a degenerative disease mainly targeting the hip joint. Searchers have determined Single Nucleotide Polymorphisms (SNPs) as major genetic elements that help initiate this disease process. Research findings show that SNPs act as direct contributors to coxarthrosis development by actively affecting the disease pathogenesis in addition to being non-random associations. SNPs have a substantial effect on cellular and molecular mechanisms which control the structural well-being and operational competence of articular cartilage together with subchondral bone. Genetic studies show SNPs enable control over signaling pathway and metabolic processes including those concerning extracellular matrix (ECM) and chondrocytes and osteocytes. The pathways control essential processes which include collagen production along with proteoglycan regulation and mechanical pressure and inflammatory response of cells. The abnormalities triggered by particular polymorphisms create problems with ECM remodeling alongside enhanced cartilage breakdown while producing bone structural modifications that are core elements of coxarthrosis. The deterioration of joint tissue caused by abnormal signaling between chondrocytes and osteocytes becomes worse because of SNP-related signaling dysfunctions. Research on genetic variants helps explain coxarthrosis origin while creating individualization strategies for both diagnostics and disease monitoring procedures and therapeutic options for reducing its progression.